AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Stegsita-M50 Forte Tablet

Prescription Icon
Prescription Required

Marketer

Metalis Lifesciences Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Stegsita-M50 Forte Tablet

For individuals with type 2 diabetes, Fortadia-M50 combines two medications to effectively manage elevated blood glucose. This dual-action approach helps mitigate severe diabetic complications like renal impairment and vision loss, potentially decreasing the risk of cardiovascular events. Fortadia-M50 may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and consistent physical activity. Dosage is individualized, considering your overall health, glucose levels, and other medications. Consuming this medication with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes therapeutic benefits; discontinuation should only occur under medical guidance. Adherence to your physician's dietary and exercise plan is crucial for diabetes management; lifestyle significantly impacts blood sugar control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this condition. This medication isn't universally suitable. Prior to use, inform your doctor of any history of hepatic, renal, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before initiating treatment. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose throughout treatment.

Uses of Stegsita-M50 Forte Tablet

Managing type 2 diabetes

Major Benefits of Stegsita-M50 Forte Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Stegsita-M50 Forte Tablets should be administered with a meal.

Common Side effects of Stegsita-M50 Forte Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Stegsita-M50 Forte Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Stegsita-M50 Forte Tablets. Ingest each tablet whole; avoid chewing, crushing, or breaking. Consume with food.

How Stegsita-M50 Forte Tablet works:

Stegsita-M50 Forte, a dual-action tablet containing sitagliptin and metformin, improves blood sugar management. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, works by decreasing liver glucose production, slowing intestinal glucose absorption, and increasing insulin sensitivity. This combined action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Stegsita-M50 Forte Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Stegsita-M50 Forte Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Stegsita-M50 Forte Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Stegsita-M50 Forte Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Stegsita-M50 Forte Tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Stegsita-M50 Forte Tablets is likely contraindicated in individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Stegsita-M50 Forte Tablet :

Should you forget a Stegsita-M50 Forte Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Stegsita-M50 Forte Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Stegsita-M50 Forte Tablet

Stegsita-M50 Forte Tablets combine sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Prolonged Stegsita-M50 Forte Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Stegsita-M50 Forte Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Stegsita-M50 Forte Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Stegsita-M50 Forte Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (like Stegsita-M50 Forte Tablet) can cause lactic acidosis, a serious, potentially life-threatening condition characterized by excessive blood lactic acid (also called Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Stegsita-M50 Forte tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is unsuitable for individuals under 18.
Stegsita-M50 Forte Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Stegsita-M50 Forte Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Stegsita-M50 Forte Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Stegsita-M50 Forte) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA—Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Stegsita-M50 Forte Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Stegsita-M50 Forte Tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Stegsita-M50 Forte Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Stegsita-M50 Forte Tablets are contraindicated in patients with known hypersensitivity to any component or excipient. Avoid use in patients with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Stegsita-M50 Forte Tablet and alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (like Stegsita-M50 Forte Tablet) can rarely cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users, so it's avoided in these groups. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking the medication and seek immediate medical attention.
Prolonged Stegsita-M50 Forte Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Stegsita-M50 Forte Tablet
189